Healthcare VCs predict more AI transparency investment, private equity M&A, and a quiet year for IPOs in 2026

As the landscape of healthcare investment evolves, venture capitalists are anticipating a significant shift in focus for 2026. After a robust year in 2025 marked by substantial funding for AI startups, particularly in the health sector, the coming year will likely see an emphasis on transparency in AI applications and a rise in mergers and acquisitions (M&A). The enthusiasm in 2025 was driven by a surge in venture capital aimed at AI health scribe startups like Abridge and Ambience Healthcare, which secured hundreds of millions in funding. However, as competitive pressures mount, notably from healthcare giants like Epic, VCs expect a diversification of investment toward startups that can demonstrate cost savings and build trust among patients and providers. Dan Mendelson, CEO of Morgan Health, highlights the need for AI to provide tangible savings for payers while easing the workload for clinicians. This shift in focus comes as insurers begin to invest in their own AI solutions, collaborating with organizations such as Palantir and Anthropic to develop tailored platforms. Todd Cozzens, cofounder of Transformation Capital, notes that the competition between insurers and healthcare startups is increasingly fierce, likening it to an arms race where significant resources will be allocated. Looking ahead, investors are keen on supporting companies that prioritize transparency and data quality in AI. Venture capitalists like Cathy Gao from Sapphire Ventures point out that a move away from opaque 'black box' AI models is essential in high-stakes healthcare environments. The next wave of innovative startups is expected to focus on creating 'glass box' platforms that clearly document AI decision-making processes. Amidst rising healthcare costs, there's also a growing interest in business models that leverage AI to streamline operations and reduce expenses. Irem Rami from Norwest anticipates a boost in in-home care services incorporating AI agents, while Mercedes Bent from Premise VC is closely monitoring startups that provide comprehensive support for specific health specialties. Despite a dip in favor for tech-enabled health services in recent years, there is renewed optimism among investors. Companies like Hinge Health and Omada Health, which have successfully gone public, are paving the way for a potential resurgence of tech-enabled services in 2026. Alyssa Jaffee from 7wireVentures emphasizes the maturation of these companies and their solid relationships with healthcare plans as key drivers of future interest. As for IPOs, while some healthtech startups are gearing up for public offerings, including Virta Health, the overall sentiment is cautious. VCs predict that 2026 might not see a wave of new public healthcare companies, but rather a significant uptick in M&A activity as private equity firms seek to acquire promising AI-driven ventures. Michael Greeley from Flare Capital Partners echoes this sentiment, noting that with interest rates stabilizing, there will be increased activity from private equity buyers targeting AI assets to enhance their existing healthcare portfolios. As the year unfolds, strategic buyers, especially health plans, are likely to become more active in seeking acquisitions, setting the stage for a dynamic exit environment in healthcare investment.